GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Beneish M-Score

Olympus (TSE:7733) Beneish M-Score : -1.72 (As of Apr. 29, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Olympus Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.72 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Olympus's Beneish M-Score or its related term are showing as below:

TSE:7733' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.52   Max: -1.72
Current: -1.72

During the past 13 years, the highest Beneish M-Score of Olympus was -1.72. The lowest was -3.10. And the median was -2.52.


Olympus Beneish M-Score Historical Data

The historical data trend for Olympus's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Beneish M-Score Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.74 -3.00 -2.78 -2.57 -2.27

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 -2.27 -1.73 -1.93 -1.72

Competitive Comparison of Olympus's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Olympus's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Olympus's Beneish M-Score falls into.



Olympus Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Olympus for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8819+0.528 * 1.0138+0.404 * 0.9351+0.892 * 1.0848+0.115 * 1.1229
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0378+4.679 * 0.163303-0.327 * 0.876
=-1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was 円165,268 Mil.
Revenue was 239070 + 228921 + 207723 + 240378 = 円916,092 Mil.
Gross Profit was 162996 + 151211 + 137226 + 163125 = 円614,558 Mil.
Total Current Assets was 円788,140 Mil.
Total Assets was 円1,468,078 Mil.
Property, Plant and Equipment(Net PPE) was 円249,417 Mil.
Depreciation, Depletion and Amortization(DDA) was 円63,563 Mil.
Selling, General, & Admin. Expense(SGA) was 円455,369 Mil.
Total Current Liabilities was 円379,955 Mil.
Long-Term Debt & Capital Lease Obligation was 円224,718 Mil.
Net Income was 18916 + -24264 + 240560 + 35215 = 円270,427 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = 円0 Mil.
Cash Flow from Operations was -1084 + 41335 + -53112 + 43547 = 円30,686 Mil.
Total Receivables was 円172,757 Mil.
Revenue was 224485 + 224795 + 192265 + 202939 = 円844,484 Mil.
Gross Profit was 156198 + 151805 + 125721 + 140633 = 円574,357 Mil.
Total Current Assets was 円722,541 Mil.
Total Assets was 円1,392,608 Mil.
Property, Plant and Equipment(Net PPE) was 円233,353 Mil.
Depreciation, Depletion and Amortization(DDA) was 円68,935 Mil.
Selling, General, & Admin. Expense(SGA) was 円404,483 Mil.
Total Current Liabilities was 円355,252 Mil.
Long-Term Debt & Capital Lease Obligation was 円299,512 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(165268 / 916092) / (172757 / 844484)
=0.180405 / 0.204571
=0.8819

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(574357 / 844484) / (614558 / 916092)
=0.680128 / 0.670847
=1.0138

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (788140 + 249417) / 1468078) / (1 - (722541 + 233353) / 1392608)
=0.293255 / 0.313594
=0.9351

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=916092 / 844484
=1.0848

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(68935 / (68935 + 233353)) / (63563 / (63563 + 249417))
=0.228044 / 0.20309
=1.1229

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(455369 / 916092) / (404483 / 844484)
=0.497078 / 0.478971
=1.0378

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((224718 + 379955) / 1468078) / ((299512 + 355252) / 1392608)
=0.411881 / 0.470171
=0.876

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(270427 - 0 - 30686) / 1468078
=0.163303

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Olympus has a M-score of -1.72 signals that the company is likely to be a manipulator.


Olympus Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Olympus's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (TSE:7733) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (TSE:7733) Headlines

No Headlines